Dr Thomas Keegan
Director of PG Research and Senior Lecturer in EpidemiologyProfile
Dr Tom Keegan joined the Division of Medicine as lecturer in epidemiology in August 2009. Before then he had worked as a researcher at the University of Oxford; on a historical cohort study of the military veterans who participated in human experiments at Porton Down between 1939 and 1989, and on environmental exposures and risk of childhood cancer.
At Lancaster, his research will continue to work in environmental and occupation epidemiology, with an interest in exposure measurement and modelling.
Research Interests
Research interests
I am interested in occupational cohorts, and am currently applying this in work on a cohort of Porton Down veterans, but am interested in applying methods and data to the broader field of military health. I am particularly interested in using our Porton Down cohort to investigate broader issues such as causes of mortality in military personnel and issues around ageing in occupational cohorts.
In collaboration with partners in Blackburn with Dawen council I recently worked on looking at prevalence of dementia in the region and how this might be a distributed across the council region. The health effects of ageing are also a theme in current work on care homes and on hospice referrals.
I am continuing to work in the field of childhood cancer, particularly in looking at possible environmental risk factors for childhood cancers.
PhD Supervision Interests
Please contact me if you have a suitable PhD proposal in the field of environmental of occupational epidemiology.
01/02/2022 → 01/12/2024
Research
04/01/2017 → 03/04/2019
Research
Invited talk
Publication peer-review
Publication peer-review
Participation in conference -Mixed Audience
Publication peer-review
Publication peer-review
Publication peer-review
Member of an organisation
Experimental Medicine
- Centre for Ageing Research
- Interdisciplinary network in culture, health, ethics and society
- Lancaster Intelligent, Robotic and Autonomous Systems Centre
- LIRA - Biomedical